LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3848 | 3970 | 0.9692 | 0.9536 |
BT-20 | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 1334 | 2491 | 3970 | 0.6273 | 0.4386 |
BT-20 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3601 | 3970 | 0.9068 | 0.8597 |
BT-20 | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 4098 | 3970 | 1.0321 | 1.0483 |
BT-20 | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 1334 | 3888 | 3970 | 0.9793 | 0.9688 |
BT-20 | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 4135 | 3970 | 1.0415 | 1.0625 |
BT-20 | Torin1 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 1429 | 3970 | 0.3600 | 0.0360 |
BT-20 | Torin2 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 996 | 3970 | 0.2510 | -0.1282 |
BT-20 | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 1334 | 1075 | 3970 | 0.2708 | -0.0984 |
BT-20 | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 1334 | 3392 | 3970 | 0.8543 | 0.7805 |
BT-20 | TWS119 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 4111 | 3970 | 1.0353 | 1.0531 |
BT-20 | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 1334 | 3974 | 3970 | 1.0009 | 1.0013 |
BT-20 | Withaferin A | 0.37 | uM | LJP5 | 72 | hr | 1334 | 2924 | 3970 | 0.7364 | 0.6030 |
BT-20 | Withaferin A | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3459 | 3970 | 0.8712 | 0.8059 |
BT-20 | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 1913 | 3970 | 0.4819 | 0.2196 |
BT-20 | WZ3105 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 839 | 3970 | 0.2114 | -0.1879 |
BT-20 | XMD11-50 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3824 | 3970 | 0.9631 | 0.9444 |
BT-20 | Y39983 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 4100 | 3970 | 1.0325 | 1.0490 |
BT-20 | YM 201636 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 3883 | 3970 | 0.9780 | 0.9669 |
BT-20 | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3685 | 3970 | 0.9280 | 0.8916 |
BT-20 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1334 | 3442 | 3970 | 0.8670 | 0.7996 |
BT-20 | Sigma A6730 | 1.11 | uM | LJP5 | 72 | hr | 1334 | 3519 | 3970 | 0.8862 | 0.8286 |
BT-20 | Alvocidib | 1.11 | uM | LJP6 | 72 | hr | 1334 | 370 | 3970 | 0.0932 | -0.3659 |
BT-20 | AT-7519 | 1.11 | uM | LJP6 | 72 | hr | 1334 | 854 | 3970 | 0.2151 | -0.1823 |
BT-20 | AZD 5438 | 1.11 | uM | LJP6 | 72 | hr | 1334 | 1736 | 3970 | 0.4374 | 0.1525 |